查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1785739

全球人工角膜植入市场

Artificial Corneal Implants
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 210 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球人工角膜植入市场规模将达1.209亿美元

全球人工角膜植入市场规模预计在2024年为8,280万美元，预计到2030年将达到1.209亿美元，在2024-2030年的分析期内，复合年增长率为6.5%。硬性人工角膜是本报告分析的细分市场之一，预计其复合年增长率为5.7%，到分析期结束时规模将达到6570万美元。软性人工角膜市场在分析期间的复合年增长率预计为7.5%。

美国市场规模估计为 2,180 万美元，中国市场预计复合年增长率为 6.4%

美国人工角膜植入市场规模预计2024年达到2,180万美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到1,950万美元，2024年至2030年的复合年增长率为6.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为5.9%和5.6%。在欧洲，预计德国的复合年增长率为5.3%。

全球人工角膜植入市场－主要趋势与驱动因素摘要

人工角膜植入如何解决视力丧失问题？

人工角膜植入彻底改变了角膜失明和角膜损伤的治疗格局，为无法接受传统角膜移植的患者提供了新的治疗选择。圆锥角膜、角膜瘢痕和营养不良等疾病使这些植入成为恢復视力的重要解决方案。生物相容性材料和手术技术的进步提高了这些植入的整合性，并降低了排斥风险。角膜疾病盛行率的上升以及全球角膜捐赠短缺，刺激了人们对人工植入的需求，使其成为可靠且方便的选择。

科技进步在改善治疗结果方面发挥什么作用？

人工角膜植入市场正经历快速的技术创新，其重点在于提高耐用性、生物相容性和手术便利性。水凝胶和奈米复合材料等先进材料能够模拟天然角膜的特性，从而提高光学清晰度并减少併发症。 3D列印技术正被用于製造患者专属的植入，从而提高精准度和治疗效果。微创手术技术也应运而生，缩短了病患恢復时间，使资源匮乏地区的病患更容易获得手术。这些技术进步使人工角膜植入成为现代眼科的基石。

为什么可访问性是市场成长的关键？

可近性是推动人工角膜植入普及的主要因素，尤其是在角膜失明负担最高的开发中国家。非政府组织和医疗保健系统正在投资宣传宣传活动并津贴治疗补贴，以缩小可及性差距。此外，经济实惠的植入的出现也使医疗资源匮乏的地区也能获得这些植入物。製造商、政府和医疗保健提供者之间的伙伴关係，确保这些改变人生的治疗能够惠及最需要的人。

是什么推动了人工角膜植入市场的成长？

人工角膜植入市场的成长动力源于角膜疾病日益增长的盛行率以及全球角膜捐赠短缺。材料科学和3D列印技术的进步使得生产耐用且针对特定患者的植入成为可能，从而改善了手术效果。人口老化加剧以及随之而来的视力丧失风险进一步推动了需求。消费者意识的提升以及政府促进眼部健康的措施正在扩大市场基础。此外，微创手术技术的进步使角膜植入更容易获得且价格更实惠，从而确保了该领域的持续成长。

部分

植入物类型（硬性人工角膜、软性人工角膜）、植入类型（合成植入、生物合成植入）、适应症（圆锥角膜适应症、眼部烧伤适应症、眼部瘢痕性类天疱疮（OCP）适应症、角膜基质营养不良适应症、Stevens-Johnson症候群（SJS）适应症、其他门诊

受访公司范例

  • AJL Ophthalmic SA
  • Aurolab
  • Beijing mikpro medical device Co., Ltd.
  • CorneaGen
  • Corneat Vision Ltd.
  • DIOPTEX GmbH
  • EyeYon Medical Ltd.
  • FCI Ophthalmics, Inc.
  • Keramed Inc.
  • LinkoCare Life Sciences AB
  • Mediphacos
  • San Diego Eye Bank

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自世界各地专家的精选内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP29231

Global Artificial Corneal Implants Market to Reach US$120.9 Million by 2030

The global market for Artificial Corneal Implants estimated at US$82.8 Million in the year 2024, is expected to reach US$120.9 Million by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Hard Keratoprosthesis, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$65.7 Million by the end of the analysis period. Growth in the Soft Keratoprosthesis segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$21.8 Million While China is Forecast to Grow at 6.4% CAGR

The Artificial Corneal Implants market in the U.S. is estimated at US$21.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$19.5 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.9% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global Artificial Corneal Implants Market - Key Trends & Drivers Summarized

How Are Artificial Corneal Implants Addressing Vision Loss?

Artificial corneal implants are transforming the treatment landscape for corneal blindness and damage, providing an alternative for patients who cannot undergo traditional corneal transplants. Conditions such as keratoconus, corneal scarring, and dystrophies have made these implants a critical solution for restoring vision. With advancements in biocompatible materials and surgical techniques, these implants offer improved integration and reduced risk of rejection. The rising prevalence of corneal diseases, coupled with a shortage of donor corneas globally, has fueled demand for artificial implants as a reliable and accessible option.

What Role Do Technological Advancements Play in Enhancing Outcomes?

The artificial corneal implant market is witnessing rapid innovation, with a focus on improving durability, biocompatibility, and surgical ease. Advanced materials such as hydrogels and nanocomposites mimic the natural cornea’s properties, ensuring better optical clarity and reduced complications. 3D printing technologies are being utilized to create patient-specific implants, enhancing precision and outcomes. Minimally invasive surgical techniques have also emerged, reducing recovery times and increasing accessibility for patients in low-resource settings. These technological strides have positioned artificial corneal implants as a cornerstone of modern ophthalmology.

Why Is Accessibility a Key Focus for Market Growth?

Accessibility is a major factor driving the adoption of artificial corneal implants, especially in developing countries where the burden of corneal blindness is highest. Non-governmental organizations and healthcare systems are investing in awareness campaigns and subsidized treatments to bridge the accessibility gap. Additionally, the emergence of cost-effective implant options has expanded availability in underserved regions. Partnerships between manufacturers, governments, and healthcare providers are ensuring that these life-changing treatments reach the people who need them most.

What Drives the Growth of the Artificial Corneal Implants Market?

The growth in the artificial corneal implants market is driven by an increasing prevalence of corneal diseases and a global shortage of donor corneas. Advancements in materials science and 3D printing have enabled the production of highly durable and patient-specific implants, improving surgical outcomes. The rise in geriatric populations and the associated risk of vision loss further boosts demand. Consumer awareness and government initiatives promoting eye health are expanding the market’s reach. Moreover, technological breakthroughs in minimally invasive procedures are making corneal implants more accessible and affordable, ensuring sustained growth in this sector.

SCOPE OF STUDY:

The report analyzes the Artificial Corneal Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Transplant Type (Hard Keratoprosthesis, Soft Keratoprosthesis); Implant Type (Synthetic Implant, Biosynthetic Implant); Indication (Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid (OCP) Indication, Corneal Stromal Dystrophies Indication, Stevens-Johnson Syndrome (SJS) Indication, Other Indications); End-Use (Hospitals End-Use, Ophthalmic Centers End-Use, Ambulatory Surgical Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • AJL Ophthalmic S.A.
  • Aurolab
  • Beijing mikpro medical device Co., Ltd.
  • CorneaGen
  • Corneat Vision Ltd.
  • DIOPTEX GmbH
  • EyeYon Medical Ltd.
  • FCI Ophthalmics, Inc.
  • Keramed Inc.
  • LinkoCare Life Sciences AB
  • Mediphacos
  • San Diego Eye Bank

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Artificial Corneal Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Corneal Blindness and Vision Disorders Driving Demand
    • Increasing Success Rates of Synthetic and Bioengineered Corneal Implants
    • Advancements in Stem Cell Therapy for Corneal Regeneration Supporting Growth
    • Growing Adoption of 3D Bioprinting Technology in Artificial Corneal Implants
    • Expansion of Minimally Invasive Corneal Implantation Techniques
    • Increasing Collaborations Between Ophthalmic Research Institutes and Manufacturers
    • Rising Geriatric Population Driving Demand for Vision Restoration Solutions
    • Advancements in Biocompatible and Long-Lasting Implant Materials
    • Expanding Access to Corneal Transplant Alternatives in Developing Countries
    • Growing Use of AI and Robotics in Corneal Implantation Surgeries
    • Surge in FDA and Regulatory Approvals for Next-Generation Implants
    • Rising Private and Government Investments in Ophthalmic Healthcare
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Corneal Implants Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Corneal Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hard Keratoprosthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Hard Keratoprosthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Soft Keratoprosthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Soft Keratoprosthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Keratoconus Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Keratoconus Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Ocular Burns Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Ocular Burns Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ocular Cicatricial Pemphigoid Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Ocular Cicatricial Pemphigoid Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Corneal Stromal Dystrophies Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Corneal Stromal Dystrophies Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Stevens-Johnson Syndrome Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Stevens-Johnson Syndrome Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Ophthalmic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Ophthalmic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Ambulatory Surgical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Synthetic Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Synthetic Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Biosynthetic Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Biosynthetic Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • JAPAN
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • CHINA
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 54: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • EUROPE
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Artificial Corneal Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • FRANCE
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 72: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • GERMANY
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • ITALY
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 96: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030

IV. COMPETITION